4.4 Review

Spinal cord injury and polypharmacy: a scoping review

Journal

DISABILITY AND REHABILITATION
Volume 42, Issue 26, Pages 3858-3870

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/09638288.2019.1610085

Keywords

Spinal cord injuries; polypharmacy; multiple medications; scoping review; medication-taking behavior

Categories

Funding

  1. Craig H. Neilsen Foundation (Psychosocial Research Pilot Grant) [441259]
  2. Connaught New Investigator Award (University of Toronto)
  3. Graduate Department of Pharmaceutical Sciences at the University of Toronto (Dean's Fund)
  4. Health System Performance Research Network Ontario Ministry of Health and Long Term Care Health Services Research Fund [06034]
  5. Canadian Institutes for Health Research Embedded Clinician Scientist Salary Award on Transitions in Care (2016-2020)
  6. Graduate Department of Pharmaceutical Sciences at the University of Toronto (Clinical, Social & Administrative Pharmacy Professors' Award for Thesis Research)
  7. Graduate Department of Pharmaceutical Sciences at the University of Toronto (Pfizer Canada Fellowship in Health Outcomes Research)

Ask authors/readers for more resources

Purpose: The purpose of this scoping review was to map the scope of the literature on polypharmacy among individuals with spinal cord injury or dysfunction (SCI/D).Material and methods: Five electronic databases were searched for literature published between January 1990 and July 2018. The following keywords were searched using Boolean operators, wild cards, proximity operators and truncations: spinal cord injuries, multiple medications, polypharmacy. The initial search identified 1,459 articles; 1,098 remained after deduplication. Following the title and abstract screen, 81 full-texts were reviewed, and 18 met all of the eligibility criteria for inclusion in the review.Results: Of the 18 studies identified, less than half defined polypharmacy. Definitions varied in the types and number of medications. Older age, higher level of injury and greater severity of injury were factors related to polypharmacy. Negative clinical outcomes, such as drug-related problems and bowel complications were identified.Conclusions: This scoping review identified a paucity of research on polypharmacy post-SCI/D, highlighting a need for future research. To improve the state of knowledge, there is a need to better understand factors and clinical outcomes related to polypharmacy in persons with SCI/D and to explore experiences of persons with SCI/D, caregivers and clinicians relating to polypharmacy.Implications for rehabilitationPrescribers should be aware of the factors and negative clinical outcomes related to polypharmacy and spinal cord injuries/dysfunction, especially for patients with higher level and more severe injuriesPrescribers should work with their patients with spinal cord injuries/dysfunction to avoid inappropriate polypharmacy and to integrate appropriate alternatives to medicationsOptimizing medication management should be a significant focus of spinal cord injury/dysfunction rehabilitation and research in order to develop targeted interventions that improve patient outcomes

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available